|
Neonatal abstinence syndrome
|
| bet | 128/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Neonatal abstinence syndrome: The optimal regimen to manage symptomatic NAS is unclear. [15] In infants with NAS secondary to opioid withdrawal, clonidine 5 microgram/kg/day up to a maximum 12 microgram/kg/day in 6-8 divided doses may reduce need for morphine treatment and duration of treatment. [7] [LOE II, GOR C]
Sedation: Evidence is insufficient to show the efficacy and safety of clonidine for sedation and analgesia in term and preterm newborn infants receiving mechanical ventilation. [8] [LOE II GOR D]
|
| |
